Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 406 participants.
Also called NCT05359224
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 406 participants
- Sponsor
- Registry
-
NCT05359224
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT05359224. Randomized; no masking; primary purpose treatment. Start 2022-06-13 (actual); primary completion 2025-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm
- Condition
- Intracranial Aneurysm
- Intervention (Drug)
- Prasugrel group
- Intervention (Drug)
- Clopidogrel group
- Lead sponsor
- Yonsei University
- Collaborator
- Severance Hospital
- Collaborator
- Gangnam Severance Hospital
- Collaborator
- Bucheon St. Mary's Hospital
- Collaborator
- International St. Mary's Hospital
- Collaborator
- Ewha Womans University Seoul Hospital
Record details
- Record id
cardio:ct-nct05359224- Content hash
461d5e12e23297df88f0b57db23c202e0b3551f3e67edcd7e08f6e6cce3a50e2